Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Joseph E. Gilliam files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas William Burns - $31.63M of GKOS open-market activity in the last 12 months
- Alex R. Thurman - $10.18M of GKOS open-market activity in the last 12 months
- Marc Stapley - $1.92M of GKOS open-market activity in the last 12 months
- Gilbert H. Kliman - $1.85M of GKOS open-market activity in the last 12 months
- Aimee S. Weisner - $1.76M of GKOS open-market activity in the last 12 months
- Tomas Navratil - $1.14M of GKOS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Joseph E. Gilliam?
Joseph E. Gilliam is a corporate insider, tracked as Director of Caris Life Sciences, Inc. (CAI). InsiderAlpha holds 19 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Joseph E. Gilliam submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Joseph E. Gilliam been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($18.05M) across all tracked filings.
Where can I see all of Joseph E. Gilliam's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Joseph E. Gilliam and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
